- 65.9k views
Covid-19 Vaccines And Adverse Reactions : Update For Family Physicians
We need to appreciate the functions of family doctors and the primary care teams in early case detection and public education during these pandemic emergencies and Vaccinations. COVID-19 vaccinations help protect people from getting COVID-19. Like with any vaccine, some people will experience mild to moderate side effects after being vaccinated. This one-hour webinar will give you the opportunity to gain insightful learning regarding the Covid-19 vaccines and adverse reactions: Update for Family Physicians, our expertise in Family medicine Dr. Raman Kumar, President of Academy of Family Physicians of India (AFPI), President of World Association of Family Physicians of the South Asia Region will help you give a better understanding and interact with all of you with all your queries.
About the Speaker
Dr. Raman Kumar
President of Academy of Family Physicians of India (AFPI), President of World Association of Family Physicians of the South Asia Region
Upcoming Case Discussions
H. pylori Treatment with PYELRA®: Best Practices
PYLERA® is a medication used for the treatment of Helicobacter pylori (H. pylori) infection, a common cause of stomach ulcers and gastritis. It contains a combination of three active ingredients: bismuth subcitrate potassium, metronidazole, and tetracycline. This combination works synergistically to eradicate H. pylori bacteria and reduce associated symptoms. Treatment with PYLERA® typically involves taking multiple capsules four times a day for a specified duration, as prescribed by a healthcare provider. It is important to follow the treatment regimen as directed and to discuss potential side effects
New Developments in Interventional Cardiology
Recent advancements in interventional cardiology have witnessed the evolution of cutting-edge techniques and technologies aimed at improving patient outcomes. From innovative stent designs to refined imaging modalities and minimally invasive procedures, interventional cardiologists now have a broader arsenal to address complex coronary artery disease. Drug-eluting stents with novel coatings aim to reduce restenosis rates, while bioresorbable scaffolds offer the promise of temporary vessel support without long-term metal implantation. Moreover, advances in imaging, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), enable more precise lesion assessment and optimized stent placement. Additionally, the advent of transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, offering a less invasive option for high-risk patients. These developments underscore the continuous pursuit of innovation in interventional cardiology, striving for enhanced patient care, and improved long-term outcomes.
Pneumonia in Children
Pneumonia in children is often caused by viral or bacterial infections, leading to inflammation of the lungs. Symptoms may include cough, fever, rapid breathing, and chest pain. Diagnosis typically involves physical examination, chest X-ray, and sometimes blood tests or other imaging studies. Treatment may include antibiotics for bacterial pneumonia, supportive care such as rest, fluids, and fever management, and in severe cases, hospitalization for oxygen therapy and close monitoring. Vaccination against common pathogens like Streptococcus pneumoniae and Haemophilus influenzae type b can help prevent pneumonia in children.
Patient Centric Care in Critical Care
Patient-centric care in critical care is a holistic approach that places the patient at the center of medical decision-making and treatment processes. It prioritizes the individual's preferences, values, and needs, considering not only their medical condition but also their emotional and psychological well-being. This approach involves clear communication, shared decision-making, and active involvement of patients and their families in care planning. Healthcare providers strive to deliver personalized care that respects the patient's dignity, autonomy, and cultural beliefs, aiming to optimize outcomes and enhance overall quality of life.
HIPEC for Ovarian Cancer
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has emerged as a promising treatment modality for advanced ovarian cancer, offering a multifaceted approach to combat this challenging disease. In HIPEC, heated chemotherapy is circulated throughout the abdominal cavity following cytoreductive surgery, targeting residual cancer cells and microscopic disease not removed by surgery alone. This localized delivery of chemotherapy at elevated temperatures enhances drug penetration, increases cytotoxicity, and disrupts tumor cell repair mechanisms. Consequently, HIPEC not only addresses macroscopic disease but also targets microscopic metastases, potentially reducing recurrence rates and improving overall survival outcomes. Despite its promising results, HIPEC requires specialized expertise and is typically reserved for select patients with advanced ovarian cancer who can tolerate aggressive surgical and chemotherapeutic approaches. Ongoing research aims to further refine patient selection criteria, optimize treatment protocols, and assess long-term outcomes to establish HIPEC's role in the comprehensive management of ovarian cancer.